Allarity Therapeutics, Inc. (ALLR) has provided an announcement.
Allarity Therapeutics, Inc. has announced they have secured a hearing before a Nasdaq hearings panel following a notice received from The Nasdaq Stock Market LLC. This development is critical for stakeholders and potential investors as it could influence the company’s stock market presence and future financial direction.
See more insights into ALLR stock on TipRanks’ Stock Analysis page.
